Publication | Closed Access

Impact of switching oral bisphosphonates to denosumab or daily teriparatide on the progression of radiographic joint destruction in patients with biologic-naïve rheumatoid arthritis

Rheumatoid DisorderRheumatologyRadiographic Joint DestructionOsteoarthritisInflammatory Rheumatic DiseaseBiologic-naïve Rheumatoid ArthritisOsteoporosisOral BisphosphonatesMedicineOrthopaedic SurgeryRheumatoid Arthritis